Home›Stock Screener›Earkart›Quarterly Results

Earkart Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹7 Cr
QMarch 2025
Quarterly Results

In 2026, Earkart (EARKART) reported revenue ₹0 Cr and net profit ₹0 Cr. For annual financials, live price and key ratios, visit EARKART screener.

EARKART Quarterly Results — Revenue, Profit & EPS Highlights

Earkart latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore EARKART share price charts to track price trends across different timeframes.

  • Revenue of ₹43 Cr in March 2025 (+0.0% vs March 2025, +34.4% vs March 2024)
  • Net Profit of ₹7 Cr in March 2025 (+0.0% vs March 2025, +133.3% vs March 2024)
  • EBITDA of ₹10 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of 23.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹6.59 in March 2025 (+0.0% vs March 2025)

Earkart Quarterly Results — Revenue, EBITDA, Net Profit & EPS

EARKART quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 0 43 32 29 6 - -
Net Profit (₹ Cr) 0 7 3 1 0 - -
EBITDA (₹ Cr) 0 10 4 2 0 - -
EPS (₹) 0.00 6.59 2.03 0.87 20.15 - -
Operating Margin (%) 0.0% 23.0% 11.0% 6.0% 2.0% - -

EARKART Share Price Trend — 1-Year Movement Across Quarterly Results

Earkart 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Compare with EARKART stock valuation models to assess whether the stock is under or overvalued.

Profitability Ratios

Profit Margin 16.3%
EBITDA Margin 23.3%
Operating Margin 23.0%
ROE (Annual) 35.0%

Balance Sheet Highlights

Total Assets ₹30 Cr
Total Equity ₹20 Cr
Current Assets ₹27 Cr
Current Liabilities ₹0 Cr

Cash Flow Analysis

Operating Cash Flow ₹1 Cr
Investing Cash Flow ₹-1 Cr
Financing Cash Flow ₹0 Cr
Net Cash Flow ₹-1 Cr

Revenue Trend (₹ Cr)

March 2023 29
March 2024 32
March 2025 43
2026 0

Net Profit Trend (₹ Cr)

March 2023 1
March 2024 3
March 2025 7
2026 0

Operating Margin Trend (%)

March 2023 6.0%
March 2024 11.0%
March 2025 23.0%
2026 0.0%

EARKART vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Earkart latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹450,643.09 Cr 1844.6 14,875 3,125 +10.8% - 21.0% 141.9
Divis Laboratories
Sept 2025 		₹179,470.03 Cr 6887.0 2,860 689 +7.1% - 24.1% 265.2
Torrent Pharmaceuti…
Sept 2025 		₹148,702.77 Cr 4486.2 3,219 591 +11.3% - 18.4% 255.8
Cipla
Mar 2026 		₹115,205.68 Cr 1399.2 6,612 543 -14.3% -4.0% 8.2% 203.7
Dr Reddys Laborator…
Mar 2026 		₹111,107.68 Cr 1307.2 7,996 221 -12.5% -11.5% 2.8% 493.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores